Arrowhead Pharmaceuticals (ARWR) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0375M750M1B2B2B2B3B3BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
03875112150188225262300Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
038M75M112M150M188M225M262M300MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EBITDA

EBITDA
-200M-112M-25M62M150M238M325M412M500MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EPS

EPSEPS Diluted
012344567Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue Variation (%)

Revenue Variation
-2004K7K11K15K19K22K26K30KQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Variation (%)

Gross Profit VariationOperating Income Variation
04K8K11K15K19K22K26K30KQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue YoY Variation (%)

Revenue YoY Variation
-1002K5K7K10K12K15K17K20KQ1 2026Q2 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
02K5K8K10K12K15K18K20KQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Price-to-Earning Ratio

P/E Ratio
-60-41-22-41534527190Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
04K8K11K15K19K22K26K30KQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0112M225M338M450M562M675M788M900MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
02581012151820Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
012345678Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0250M500M750M1B1B2B2B2BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Cash Flow to Debt Ratio

Cash At End Of Period
038M75M112M150M188M225M262M300MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
🏦 Balance Sheet
📈 Key Metrics